Market Dynamics

Genomics uses a combination of recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyze the structure and function of genomes. Increasing government spending on development present biotechnology infrastructure and focus on various collaborative works for introduction of innovative solutions are major factors expected to drive the growth of global market. In addition, major players focus on lowering the sequencing cost, coupled with inclination towards enhancing the product portfolio are factors expected to support the growth of target market.

Major players focus on developing the business their inclination towards increasing customer base and enhance the profit ration this is expected to augment the growth of target market.

In 2020, Roche a multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics acquired Stratos Genomics. The acquisition is expected to help the company to develop DNA based sequencing for diagnostic use and enhance the product portfolio.

In 2020, BioNano Genomics, Inc. a global provider of platform to analyze the long segments of genomic DNA and other biomolecules structural variations acquired Lineagen, Inc. The acquisition is expected to help the company to provide centralized lab services as well as a platform technology and increase the customer base.

In 2020, Ancestry.com LLC is a privately held online company launched next generation sequencing product that is expected to help the customers gain insights into their healt

However, factors such as high cost of genomic equipment and lack of trained professionals are expeh and risk factors. This product launch is expected to help the company to enhance the customer base and increase the revenue share.

In 2020, the company acquired Lineagen that is provider of genetic diagnostic services covering childhood neurodevelopmental disorders and autism spectrum disorder. This acquisition will help the company to enhance the product portfolio and increase the revenue.

In 2020, Nebula Genomics a global provider of privacy-focused personal genomics service launched direct-to-consumer whole genome sequencing. This launch is expected to help the company to increase the revenue share.cted to hamper the growth of global genomics market. In addition, unavailability of developed infrastructure in developing countries is expected to challenge the growth of target market.

Rapid technological advancements by major players and focus on use of genomics in specialized/personalized medicine are factors expected to create new opportunities for players operating in the target market over the forecast period.

Segment Analysis by Region

The market in North America is expected to account for major revenue share due to high government spending on biotechnology sector. In addition, presence of large number of players operating in the country and focus on introduction of innovative service & solutions in order to attract new customers are factors expected to support the growth of target market.

Moreover, increasing business acquisition activities in order to strengthen the business is another factor expected to impact the growth of target market.

Competitive Landscape                                                                                 

The global market is high highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.

Report coverage

 Genomics Market Segment Analysis, 2019

The global market is segmented into product & services, technology, application, and end use. The product & service segment is bifurcated into consumables, systems and software, and services. Among the product & service the system & service segment is expected to account for significant revenue share in the target market. The end use segment is divided into research centers and academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and other. Among the end use the hospitals & clinics segment is expected to account for major revenue share in the global market.

The players profiled in the report are Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., 23andMe, Inc., Illumina, Inc., Myriad Genetics, Inc., Foundation Medicine, Inc., Danaher; Pacific Biosciences, F. Hoffmann-La Roche Ltd.., Agilent Technologies, Oxford Nanopore Technologies, and BGI.

Market Segmentation

Market By Product & Services

Consumables

Systems and software

Services

Market By Technology

Sequencing

Microarray

PCR (polymerase chain reaction)

Nucleic acid extraction and purification

Other

Market By Application

Diagnostics

Drug discovery and development

Precision medicine

Agriculture and animal research

Other

Market By End Use

Research centers and academic & government institutes

Hospitals & clinics

Pharmaceutical & biotechnology companies

Other

Market By Region

North America

• U.S.
• Canada

Europe

• UK
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC
• South Africa
• Rest of Middle East & Africa